Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

Liwang New Energy Explores New Lithium Battery Products

Business by 2FIRSTS.ai
Jan.16.2024
Liwang New Energy Explores New Lithium Battery Products
Guangdong Liwang New Energy Co., Ltd. received three institutional visits and highlighted its advantages and future plans in the lithium-ion battery business.

On January 13th, Guangdong Liwang New Energy Co., Ltd. (831627) hosted research visits from three institutions, providing detailed information about the company's competitive advantages and future development plans in the field of lithium-ion batteries.

 

Li Wang New Energy states that it is currently researching and developing new lithium battery products such as 1.5V lithium batteries, Bluetooth batteries, smart wearable lithium batteries, and soft-pack lithium batteries. Some potential customers, including Zidan Alkiswani&Partners Co. from overseas and Fulikai Medical Supplies (Dongguan) Co., Ltd. from domestic market, are currently in negotiations. In addition, longstanding customers like Shenzhen ALD Technology Co., Ltd. and Shenzhen Sail-Mate Electronic Technology Co., Ltd. also have new demand for lithium batteries in non-e-cigarette applications.

 

References:
[1] 力王股份：现在在研究和开发新的锂电池产品有1.5V锂电池、蓝牙电池等
Also Read:
[1] ALD Introduces FRESOR: Technology Brand for E-cigarettes
[2] Behind the Scenes: Preparations at IECIEVape Show Jakarta 2023
#Asia#China#Products#Energy drinks#Lithium batteries#British American Tobacco (BAT)#Product

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Eleventh session of the Conference of the Parties (COP11) to the WHO FCTC
Eleventh session of the Conference of the Parties (COP11) to the WHO FCTC
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
XQS Rolls Out Two Beverage-Flavoured Nicotine Pouches in UK; Says Convenience Stores Are the Fastest-Growing Channel
XQS Rolls Out Two Beverage-Flavoured Nicotine Pouches in UK; Says Convenience Stores Are the Fastest-Growing Channel
Scandinavian Tobacco Group (STG) UK has added two beverage-inspired variants—Cola Lime and Fizzy Peach—to its XQS nicotine pouch range. Both come in an 8mg strength and are available exclusively via the Vape Supplier website, with a recommended retail price of £5.50.
Oct.29 by 2FIRSTS.ai
Pakistan Advances E-Cigarette Legislation: Proposed Minor Sales Ban, Limits on Public Use and Ads
Pakistan Advances E-Cigarette Legislation: Proposed Minor Sales Ban, Limits on Public Use and Ads
A Pakistani senator has introduced a bill to ban sales of e-cigarettes and e-shisha to under-18s, prohibit their use in public places, and restrict advertising, promotions, and sponsorships to limit youth exposure to nicotine products.
Oct.10 by 2FIRSTS.ai
Ireland implements new regulations banning sale of tobacco products through vending machines​, aims to reduce smoking rate to below 5%​.
Ireland implements new regulations banning sale of tobacco products through vending machines​, aims to reduce smoking rate to below 5%​.
Ireland bans sale of cigarettes, e-cigarettes from vending machines to reduce smoking rates, underage access.
Sep.29 by 2FIRSTS.ai
ASDF responds to Malaysia's proposed e-cigarette ban: Implementation prospects remain unclear; urges compliant operations and diversified strategies
ASDF responds to Malaysia's proposed e-cigarette ban: Implementation prospects remain unclear; urges compliant operations and diversified strategies
Regarding the Malaysian government's plan to implement a nationwide ban on the sale and use of e-cigarettes in phases from mid-2026, local e-cigarette brand ASDF told 2Firsts that this move reflects the government's concerns over public health, youth protection and market regulation. However, uncertainties remain regarding the specific implementation methods and pace of enforcement for the policy.
Sep.29
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.
Nov.14 by 2FIRSTS.ai
Related Topics
News Company
Related Read
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
2FIRSTS.ai
XQS Rolls Out Two Beverage-Flavoured Nicotine Pouches in UK; Says Convenience Stores Are the Fastest-Growing Channel
XQS Rolls Out Two Beverage-Flavoured Nicotine Pouches in UK; Says Convenience Stores Are the Fastest-Growing Channel
2FIRSTS.ai
Pakistan Advances E-Cigarette Legislation: Proposed Minor Sales Ban, Limits on Public Use and Ads
Pakistan Advances E-Cigarette Legislation: Proposed Minor Sales Ban, Limits on Public Use and Ads
2FIRSTS.ai
Ireland implements new regulations banning sale of tobacco products through vending machines​, aims to reduce smoking rate to below 5%​.
Ireland implements new regulations banning sale of tobacco products through vending machines​, aims to reduce smoking rate to below 5%​.
2FIRSTS.ai
ASDF responds to Malaysia's proposed e-cigarette ban: Implementation prospects remain unclear; urges compliant operations and diversified strategies
ASDF responds to Malaysia's proposed e-cigarette ban: Implementation prospects remain unclear; urges compliant operations and diversified strategies
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
2FIRSTS.ai
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://cn.2firsts.com
English
English
中文